| The somatic genomic landscape of glioblastoma CW Brennan, RGW Verhaak, A McKenna, B Campos, H Noushmehr, ... cell 155 (2), 462-477, 2013 | 4923 | 2013 |
| Clonal evolution of glioblastoma under therapy J Wang, E Cazzato, E Ladewig, V Frattini, DIS Rosenbloom, S Zairis, ... Nature genetics 48 (7), 768-776, 2016 | 698 | 2016 |
| Physical rehabilitation has a positive effect on disability in multiple sclerosis patients A Solari, G Filippini, P Gasco, L Colla, A Salmaggi, L La Mantia, ... Neurology 52 (1), 57-57, 1999 | 347 | 1999 |
| Regorafenib compared with lomustine in patients with relapsed glioblastoma (REGOMA): a multicentre, open-label, randomised, controlled, phase 2 trial G Lombardi, GL De Salvo, AA Brandes, M Eoli, R Rudà, M Faedi, I Lolli, ... The Lancet Oncology 20 (1), 110-119, 2019 | 291 | 2019 |
| Detection, characterization, and inhibition of FGFR–TACC fusions in IDH wild-type glioma AL Di Stefano, A Fucci, V Frattini, M Labussiere, K Mokhtari, P Zoppoli, ... Clinical cancer research 21 (14), 3307-3317, 2015 | 250 | 2015 |
| Methylation of O6-Methylguanine DNA Methyltransferase and Loss of Heterozygosity on 19q and/or 17p Are Overlapping Features of Secondary Glioblastomas … M Eoli, F Menghi, MG Bruzzone, T De Simone, L Valletta, B Pollo, ... Clinical Cancer Research 13 (9), 2606-2613, 2007 | 202 | 2007 |
| Genotype-phenotype correlation in NF1: evidence for a more severe phenotype associated with missense mutations affecting NF1 codons 844–848 M Koczkowska, Y Chen, T Callens, A Gomes, A Sharp, S Johnson, ... The American Journal of Human Genetics 102 (1), 69-87, 2018 | 193 | 2018 |
| Fluorescein-guided surgery for resection of high-grade gliomas: a multicentric prospective phase II study (FLUOGLIO) F Acerbi, M Broggi, KM Schebesch, J Höhne, C Cavallo, C De Laurentis, ... Clinical Cancer Research 24 (1), 52-61, 2018 | 181 | 2018 |
| Intracavitary VEGF, bFGF, IL-8, IL-12 levels in primary and recurrent malignant glioma A Salmaggi, M Eoli, S Frigerio, A Silvani, M Gelati, E Corsini, G Broggi, ... Journal of neuro-oncology 62, 297-303, 2003 | 180 | 2003 |
| Is fluorescein-guided technique able to help in resection of high-grade gliomas? F Acerbi, M Broggi, M Eoli, E Anghileri, C Cavallo, C Boffano, R Cordella, ... Neurosurgical focus 36 (2), E5, 2014 | 170 | 2014 |
| The molecular landscape of glioma in patients with Neurofibromatosis 1 F D’Angelo, M Ceccarelli, Tala, L Garofano, J Zhang, V Frattini, FP Caruso, ... Nature medicine 25 (1), 176-187, 2019 | 163 | 2019 |
| INTELLANCE 2/EORTC 1410 randomized phase II study of Depatux-M alone and with temozolomide vs temozolomide or lomustine in recurrent EGFR amplified glioblastoma M Van Den Bent, M Eoli, JM Sepulveda, M Smits, A Walenkamp, ... Neuro-oncology 22 (5), 684-693, 2020 | 160 | 2020 |
| Overlapping phenotypes in complex spastic paraplegias SPG11, SPG15, SPG35 and SPG48 V Pensato, B Castellotti, C Gellera, D Pareyson, C Ciano, L Nanetti, ... Brain 137 (7), 1907-1920, 2014 | 159 | 2014 |
| Phenotypic manifestations associated with CAG-repeat expansion in the androgen receptor gene in male patients and heterozygous females: a clinical and molecular study of 30 … C Mariotti, B Castellotti, D Pareyson, D Testa, M Eoli, C Antozzi, V Silani, ... Neuromuscular Disorders 10 (6), 391-397, 2000 | 155 | 2000 |
| Fluorescein-guided surgery for grade IV gliomas with a dedicated filter on the surgical microscope: preliminary results in 12 cases F Acerbi, M Broggi, M Eoli, E Anghileri, L Cuppini, B Pollo, M Schiariti, ... Acta neurochirurgica 155, 1277-1286, 2013 | 140 | 2013 |
| High-resolution genomic copy number profiling of glioblastoma multiforme by single nucleotide polymorphism DNA microarray D Yin, S Ogawa, N Kawamata, P Tunici, G Finocchiaro, M Eoli, C Ruckert, ... Molecular Cancer Research 7 (5), 665-677, 2009 | 129 | 2009 |
| Clinical spectrum of individuals with pathogenic NF1 missense variants affecting p.Met1149, p.Arg1276, and p.Lys1423: genotype–phenotype study in … M Koczkowska, T Callens, Y Chen, A Gomes, AD Hicks, A Sharp, E Johns, ... Human mutation 41 (1), 299-315, 2020 | 109 | 2020 |
| Fluorescein-guided surgery for malignant gliomas: a review F Acerbi, C Cavallo, M Broggi, R Cordella, E Anghileri, M Eoli, M Schiariti, ... Neurosurgical review 37, 547-557, 2014 | 104 | 2014 |
| NEDD9, a novel target of miR-145, increases the invasiveness of glioblastoma MC Speranza, V Frattini, F Pisati, D Kapetis, P Porrati, M Eoli, S Pellegatta, ... Oncotarget 3 (7), 723, 2012 | 101 | 2012 |
| CXCL12 in malignant glial tumors: a possible role in angiogenesis and cross-talk between endothelial and tumoral cells A Salmaggi, M Gelati, B Pollo, S Frigerio, M Eoli, A Silvani, G Broggi, ... Journal of neuro-oncology 67, 305-317, 2004 | 96 | 2004 |
